Vanda Pharmaceuticals Inc (USD)
VNDA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range10.47 | 11.30
52-Wk Range |
Last Close10.61
Mkt Cap (m)569.21
Dividend yield-
ISINUS9216591084
Volume698,046
Exchange VenueNAS

Company Profile

Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.

Key Information
Price/Earning5.03
Price/Book1.39
Price/Sales2.56
P/CF12.67
Rev Growth (3 year avg)15.88
EPS Growth (3 year avg)-
Operating Margin % 10.04
Net Margin %50.86
Return on Equity33.67
Debt/Equity0.04

Documents

Prospectus
en 16/03/2018
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)50110146165193227
Operating Income (m)-58-40-19-172223
Net Income (m)20-40-18-1625116
Basic EPS0.58-0.94-0.41-0.350.502.17
Avg. Diluted Shares Outstanding (m)374243455355
Balance Sheet
USD201420152016201720182019
Current Assets (m)142167174170299354
Non Current Assets (m)3047363633130
Total Assets (m)172213210205332484
Current Liabilities (m)85150705360
Total Liabilities (m)------
Total Equity (m)161133131131275411
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-8212-8-23046
Capital Expenditure (m)-9-3-1-2-25-1
Figures are quoted in USD unless stated otherwise
-
No change
$
10.61
Last Price